Johnson & Johnson is trading at €225.75, down 3.03%, amid broader market pressure. - No clear company-specific catalyst surfaced; the decline appears consistent with geopolitical and rate-related risk aversion, rather than a newly announced Johnson & Johnson event. - Reuters reported rising oil prices and Treasury yields were weighing on U.S. stocks, with healthcare among the weakest sectors. - The supplied sector context puts healthcare down 1.49%.